These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18256928)

  • 1. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.
    Phoenix KN; Vumbaca F; Claffey KP
    Breast Cancer Res Treat; 2009 Jan; 113(1):101-11. PubMed ID: 18256928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.
    Hadad SM; Appleyard V; Thompson AM
    Breast Cancer Res Treat; 2009 Mar; 114(2):391. PubMed ID: 18421577
    [No Abstract]   [Full Text] [Related]  

  • 3. Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer.
    Mauro L; Naimo GD; Gelsomino L; Malivindi R; Bruno L; Pellegrino M; Tarallo R; Memoli D; Weisz A; Panno ML; Andò S
    FASEB J; 2018 Aug; 32(8):4343-4355. PubMed ID: 29513571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines.
    Bandyopadhyay A; Wang L; Chin SH; Sun LZ
    Neoplasia; 2007 Feb; 9(2):113-8. PubMed ID: 17356707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.
    Kim J; Lee J; Jang SY; Kim C; Choi Y; Kim A
    Oncol Rep; 2016 May; 35(5):2553-60. PubMed ID: 26986571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours.
    Cai H; Everett RS; Thakker DR
    Br J Pharmacol; 2019 Aug; 176(15):2724-2735. PubMed ID: 31032880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
    Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
    Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
    Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
    Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
    Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
    Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
    Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin induces unique biological and molecular responses in triple negative breast cancer cells.
    Liu B; Fan Z; Edgerton SM; Deng XS; Alimova IN; Lind SE; Thor AD
    Cell Cycle; 2009 Jul; 8(13):2031-40. PubMed ID: 19440038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
    IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad4 inhibits tumor growth by inducing apoptosis in estrogen receptor-alpha-positive breast cancer cells.
    Li Q; Wu L; Oelschlager DK; Wan M; Stockard CR; Grizzle WE; Wang N; Chen H; Sun Y; Cao X
    J Biol Chem; 2005 Jul; 280(29):27022-8. PubMed ID: 15886208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Receptor Is Required for Metformin-Induced Apoptosis in Breast Cancer Cells Under Hyperglycemic Conditions.
    Sekar AP; Nurmala S; Matsuura E; Tan XW; Rahmasari R; Sauriasari R
    Breast Cancer (Auckl); 2024; 18():11782234241240173. PubMed ID: 38779416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Furanodienone inhibits cell proliferation and survival by suppressing ERα signaling in human breast cancer MCF-7 cells.
    Li YW; Zhu GY; Shen XL; Chu JH; Yu ZL; Fong WF
    J Cell Biochem; 2011 Jan; 112(1):217-24. PubMed ID: 21069738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
    Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
    Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
    Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
    Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.
    Anbalagan M; Sheng M; Fleischer B; Zhang Y; Gao Y; Hoang V; Matossian M; Burks HE; Burow ME; Collins-Burow BM; Hangauer D; Rowan BG
    Mol Cancer Res; 2017 Nov; 15(11):1491-1502. PubMed ID: 28751463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.